
Weight-loss drug Mounjaro not value for money for public patients, finds study
12/4/2025
0:00
8:14
Professor Michael Barry, Clinical Director for the National Centre for Pharmacoeconomics, on the cost of making the weight loss drug Mounjaro available to public patients.
See omnystudio.com/listener for privacy information.
More episodes from "Morning Ireland"



Don't miss an episode of “Morning Ireland” and subscribe to it in the GetPodcast app.







